Literature DB >> 9324086

F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus.

H Andersen1, E Stålberg, B Falck.   

Abstract

In this study we examined the diagnostic sensitivity of minimal F-wave latency, F-wave persistence, motor nerve conduction velocity (MCV), and amplitude of the compound motor action potential (CMAP) of the median, ulnar, tibial, and peroneal nerves, and of sensory conduction velocity (SCV) and sensory nerve action potential (SNAP) amplitude of the sural nerve in 82 diabetic patients. For the median, ulnar, and tibial nerves the Z scores of the minimal F-wave latency were significantly larger than those of the MCV, and for all four motor nerves the Z scores of the minimal F-wave latency were significantly larger than those of the amplitude of the CMAP. The Z scores of the peroneal minimal F-wave latency exceeded those of peroneal MCV, sural SCV, and sural SNAP. F-wave persistence did not differ significantly from the reference values. In conclusion, minimal F-wave latency is the most sensitive measure for detection of nerve pathology and should be considered in electrophysiological studies of diabetic patients.

Entities:  

Mesh:

Year:  1997        PMID: 9324086     DOI: 10.1002/(sici)1097-4598(199710)20:10<1296::aid-mus12>3.0.co;2-1

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  17 in total

1.  Central motor conduction after magnetic stimulation in diabetes.

Authors:  A Moglia; A Arrigo; M Maurelli; E Alfonsi; A Bodini; A Lozza; M T Tenconi; S B Solerte; E Ferrari
Journal:  Ital J Neurol Sci       Date:  1998-02

2.  The medial plantar and medial peroneal cutaneous nerve conduction studies for diabetic polyneuropathy.

Authors:  Yasar Altun; Ahmet Demirkol; Yener Tumay; Kazım Ekmekci; Ibrahim Unsal; Ahmet Candan Koyluoglu; Yasar Ozkul
Journal:  Neurol Sci       Date:  2011-07-01       Impact factor: 3.307

3.  Motor neurone excitability in back muscles assessed using mechanically evoked reflexes in spinal cord injured patients.

Authors:  A Kuppuswamy; S Theodorou; M Catley; P H Strutton; P H Ellaway; A H McGregor; N J Davey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

4.  Utilization of nerve conduction studies for the diagnosis of polyneuropathy in patients with diabetes: a retrospective analysis of a large patient series.

Authors:  Xuan Kong; Eugene A Lesser; Frisso A Potts; Shai N Gozani
Journal:  J Diabetes Sci Technol       Date:  2008-03

Review 5.  Distal Sensorimotor Neuropathy: Improvements in Diagnosis.

Authors:  Prashanth R J Vas; Sanjeev Sharma; Gerry Rayman
Journal:  Rev Diabet Stud       Date:  2015-08-10

6.  Nerve conduction study of the superficial peroneal sensory distal branches in koreans.

Authors:  Yeong-A Ko; Young Jin Ko; Hye Won Kim; Seong Hoon Lim; Byung Woo Yang; Sung-Hee Jung; Sun Im
Journal:  Ann Rehabil Med       Date:  2011-08-31

7.  Association between Diabetic Polyneuropathy and Cardiovascular Complications in Type 2 Diabetic Patients.

Authors:  Jin Ook Chung; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Diabetes Metab J       Date:  2011-08-31       Impact factor: 5.376

8.  A comparative study of reaction times between type II diabetics and non-diabetics.

Authors:  Samantha J Richerson; Charles J Robinson; Judy Shum
Journal:  Biomed Eng Online       Date:  2005-02-21       Impact factor: 2.819

9.  Association of peripheral nerve conduction in diabetic neuropathy with subclinical left ventricular systolic dysfunction.

Authors:  Yasuhide Mochizuki; Hidekazu Tanaka; Kensuke Matsumoto; Hiroyuki Sano; Hiromi Toki; Hiroyuki Shimoura; Junichi Ooka; Takuma Sawa; Yoshiki Motoji; Keiko Ryo; Yushi Hirota; Wataru Ogawa; Ken-ichi Hirata
Journal:  Cardiovasc Diabetol       Date:  2015-05-07       Impact factor: 9.951

10.  Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters.

Authors:  Alanna Weisman; Vera Bril; Mylan Ngo; Leif E Lovblom; Elise M Halpern; Andrej Orszag; Bruce A Perkins
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.